INOmax (INO Therapeutics)


Welcome to the PulseAid listing for the INOmax drug offered from INO Therapeutics. This Vasodilation [PE],Vasodilator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: INO Therapeutics
NON-PROPRIETARY NAME: nitric oxide
SUBSTANCE NAME: NITRIC OXIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vasodilation [PE],Vasodilator [EPC]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: GAS
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1999-12-23
END MARKETING DATE: 0000-00-00


INOmax HUMAN PRESCRIPTION DRUG Details:

Item DescriptionINOmax from INO Therapeutics
LABELER NAME: INO Therapeutics
DEA SCHEDULE:
ACTIVE STRENGTH: 0.98(mg/L)
START MARKETING DATE: 1999-12-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64693-002_e2e37ae9-824f-47a2-8638-3b627db10d3e
PRODUCT NDC: 64693-002
APPLICATION NUMBER: NDA020845

Other NITRIC OXIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
INO TherapeuticsINOmax